Neuroinflammatory Diseases: all 180 studies

Page 2 of 2. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Autoreactive Autoantibodies on Peripheral and Central Disease Mechanisms in Fibromyalgia.CompletedNCT07346950
• Dynamics of microRNA Expression and Systemic Inflammatory Response in POCD After Cardiac SurgeryCompletedNCT07231731
• A Study of NTRX-07 in Participants With Alzheimer's DiseaseCompletedNCT07058688Phase 2
• Neuroinflammation in FTLDActive, not recruitingNCT06870838
• Biomarkers for Monitoring Dementia ProgressionCompletedNCT06855368
• The Unhide™ Project: Economic Impact Study of IVIG Treatment for PANSCompletedNCT06818656
• A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's DiseaseActive, not recruitingNCT06816810Phase 2
• A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsCompletedNCT06745583Phase 2
• PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFCompletedNCT06683612Phase 1
• Relationships of Affect and Neuroinflammation With Clinical Pain in Veterans With FibromyalgiaActive, not recruitingNCT06574165Not applicable
• Brain Cooling BiomarkersCompletedNCT06542419Not applicable
• Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac SurgeryWithdrawnNCT06480708Not applicable
• The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly IndividualsCompletedNCT06404203Not applicable
• The Effect of Intravenous Versus Volatile Anesthesia on Postoperative Cognitive Dysfunction in Elderly PatientsCompletedNCT06353516Not applicable
• Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentCompletedNCT06322342Phase 2
• Exercise Intensity on Brain & Mental Health in StressCompletedNCT06245538Not applicable
• Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's DiseaseCompletedNCT06224920
• A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral HaemorrhageCompletedNCT05970224Phase 2
• Impact of Microglial Activation on Synaptic Density in Alzheimer's DiseaseActive, not recruitingNCT05911178Not applicable
• CNS Correlates of Extended Sleep RestrictionCompletedNCT05547880
• Clinicopathological MRI and CSF Correlates in Huntington's Disease.Status unknownNCT05534139
• Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early ADActive, not recruitingNCT05468073Phase 2
• Safety & PK of Single Doses of MT1980CompletedNCT05429840Phase 1
• Neuroinflammation and Alzheimer's Pathology in POCDStatus unknownNCT05378659
• Extracellular Vesicles as Stroke BiomarkersCompletedNCT05370105
• Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19CompletedNCT05133596Not applicable
• Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive RecoveryTerminatedNCT05129514Not applicable
• A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid ReconstructionTerminatedNCT05126238Phase 3
• Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary DeficiencyCompletedNCT05040256
• Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)Active, not recruitingNCT05020535Phase 2
• Assessment of Inflammation in Primary HeadachesCompletedNCT04891848
• The Effect of Celecoxib on Neuroinflammation in MDDCompletedNCT04814355Phase 4
• Neuroinflammation in Patients With OCDCompletedNCT04786548Phase 2
• Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain InjuryStatus unknownNCT04489160Phase 2
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
• Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and PsoriasisWithdrawnNCT04423471
• Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19Status unknownNCT04413864Not applicable
• The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive ImpairmentStatus unknownNCT04318626Phase 2
• CSF/Serum Biomarkers in Predicting PND/Persistent Pain After CesareanCompletedNCT04271072
• Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive OutcomeCompletedNCT04266665Phase 4
• Lifestyle Remodeling in Subjective Memory Complaint (SMC): Brain Imaging and Blood Biochemistry StudyCompletedNCT04162990Not applicable
• Neuroinflammation During ICU-associated Delirium in Critically Ill Patients and Its Association With Structural and Functional Brain Alterations: a Nested Case-control StudyStatus unknownNCT04078503
• Imaging of Neuro-Inflammation and the Risk for Post-Traumatic EpilepsyActive, not recruitingNCT03999164Phase 1
• Minocycline as Adjunctive Treatment for Treatment Resistant DepressionCompletedNCT03947827Phase 3
• Co-ultra PEALut Enhances Neuronal Recovery Following Moderate Traumatic Brain InjuryStatus unknownNCT03818451Not applicable
• Mindfulness Therapy for Chronic MigraineCompletedNCT03671681Phase 4
• Parkinson's Disease Inflammatory Biomarker ProfilingTerminatedNCT03633513
• Neuroinflammatory Response and Headache Control in Patients After Subarachnoid HemorrhageActive, not recruitingNCT03604276
• Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific InflammationCompletedNCT03523130
• Cognitive Impairment Following Elective Spine SurgeryTerminatedNCT03486288
• Brain Network Disruptions Related to Traumatic ComaCompletedNCT03482115Not applicable
• Perioperative Research Into Memory: Cognitive Outcome Following Major BurnsCompletedNCT03470844
• Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPACompletedNCT03452722
• The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CISCompletedNCT03451955Not applicable
• Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine UsersCompletedNCT03341078Phase 2
• PRIME: Cognitive Outcome Following Major BurnsCompletedNCT03242395
• Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisWithdrawnNCT03236090Not applicable
• Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET TacerCompletedNCT03100136Phase 1
• Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU StudyActive, not recruitingNCT03098459
• The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.CompletedNCT03058328
• Biomarkers as Predictors of Suicidal Risk in AdolescentsCompletedNCT03014518
• Investigating the Neuropathology of Obstructive Sleep ApnoeaCompletedNCT02967536
• Clinical Trial of the Use of Ketamine in Treatment Resistant DepressionStatus unknownNCT02610712Phase 4
• Hereditary Parkinson s Disease Natural History ProtocolCompletedNCT02511015
• Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PETStatus unknownNCT02319382Not applicable
• Evaluation of Neuroinflammation in Children With Infantile SpasmsCompletedNCT02092883Phase 4
• Psychosis-Associated Neuroinflammation in SchizophreniaCompletedNCT02009826
• Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal SurgeryCompletedNCT01881646Phase 4
• Brain Inflammation in Major Depressive Disorder BackgroundCompletedNCT01851356
• Mild Neurocognitive Disorder in HIV Infection of the BrainTerminatedNCT01547754
• A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple SclerosisCompletedNCT01538355Not applicable
• Neuroinflammation and Bispectral Index After Subarachnoid HemorrhageStatus unknownNCT01516671
• To Rescue Cognition With ValaciclovirCompletedNCT01364792Phase 2
• Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy VolunteersCompletedNCT01035164Phase 1
• Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy VolunteersCompletedNCT01031199Phase 1
• Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic PainStatus unknownNCT00850005Phase 2
• PET Imaging of Peripheral Benzodiazepine ReceptorsCompletedNCT00696371
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBCompletedNCT00527579Phase 1
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28CompletedNCT00526916Phase 1
• Central Nervous System Disease in HIV-infected Children on HAARTCompletedNCT00110331

← Neuroinflammatory Diseases overview